ResMed Inc. (RMD)

Market Cap	30.31B
Revenue (ttm)	4.58B
Net Income (ttm)	958.38M
Shares Out	146.91M
EPS (ttm)	6.51
PE Ratio	31.69
Forward PE	24.97
Dividend	$1.92 (0.93%)
Ex-Dividend Date	May 8, 2024

Volume	786,766
Open	209.10
Previous Close	209.34
Day's Range	205.00 - 211.10
52-Week Range	132.24 - 229.97
Beta	0.64
Analysts	Buy
Price Target	212.30 (+2.89%)
Earnings Date	Apr 25, 2024

About RMD

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Jun 2, 1995
• Employees: 10,140
• Stock Exchange: NYSE
• Ticker Symbol: RMD

Financial Performance

In 2023, ResMed's revenue was $4.22 billion, an increase of 18.02% compared to the previous year's $3.58 billion. Earnings were $897.56 million, an increase of 15.15%.

Analyst Forecast

According to 11 analysts, the average rating for RMD stock is "Buy." The 12-month stock price forecast is $212.3, which is an increase of 2.89% from the latest price.

Price Target

$212.3

(2.89% upside)

Analyst Consensus: Buy